Related Experiment Video
Updated: Aug 16, 2026

10:05
Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
Published on: May 24, 2011
Morantel resistance in Trichostrongylus colubriformis
1Palmerston North Animal Health Laboratory, PO Box 1654, Palmerston North.
New Zealand Veterinary Journal
|October 1, 1985
Abstract:
The occurrence of anthelmintic resistance in Trochostrongylus colubriformis and resistance to morantel are reported for the first time in New Zealand. In two controlled anthelmintic trials with experimentally infected sheep, morantel citrate at either 8.8 mg/kg or 10 mg/kg had no effect on worm burden. An efficacy of >99% was demonstrated for mebendazole at 12.5 mg/kg against this strain.
Related Concept Videos
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

